AT-Patch (ATP-C130/ATP-C70) vs Bunkerhill AVC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by ATsens Co.
VS
by Bunkerhill Health

AI Verdict

These tools are adjacent in their application of AI to cardiology but serve distinct purposes. AT-Patch focuses on continuous ECG monitoring via a wearable device for arrhythmia detection, providing insights into electrical heart activity. In contrast, Bunkerhill AVC utilizes generative AI to analyze CT scans for the automated detection and quantification of cardiac and vascular calcifications, addressing structural heart health and clinical reasoning from imaging data.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if your clinical practice requires extended, continuous ambulatory ECG monitoring for patients in their natural environment, particularly when investigating intermittent arrhythmias or needing up to 14 days of cardiac rhythm data. Its wearable, shower-proof design and integrated AI analysis make it ideal for convenient patient use and efficient arrhythmia detection without requiring frequent device interaction.

View AT-Patch (ATP-C130/ATP-C70) →

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your institution seeks to leverage generative AI for opportunistic screening and quantification of cardiovascular calcifications, such as aortic valve calcification, directly from existing chest CT scans. This tool is best suited for integrating into radiology and cardiology workflows to provide automated clinical decision support and improve early detection of cardiac conditions from routine imaging.

View Bunkerhill AVC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AT-Patch (ATP-C130/ATP-C70) Bunkerhill AVC
Deployment Wearable device for patients; analysis software deployed on-premise at medical institutions. Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch prioritizes patient usability with its compact, lightweight, and shower-proof wearable device, enhancing comfort for continuous monitoring. The accompanying AT-Note smartphone app allows for easy live ECG viewing and symptom recording, making it user-friendly for patients during their daily activities.

Clinical Value

Bunkerhill AVC

Bunkerhill AVC offers broader clinical utility by opportunistically detecting and quantifying multiple critical conditions (aortic, coronary, and mitral valve calcification, and bone density) from existing chest CT scans. Its generative AI platform integrates with EHRs to provide clinical reasoning and automate workflows, potentially leading to earlier detection and proactive management of various diseases.

Pricing & Value

Tie

Neither AT-Patch nor Bunkerhill AVC provides publicly available pricing information. Both require direct contact with the company for pricing details, making a direct comparison of their cost-effectiveness or value proposition impossible without further information.

Enterprise Readiness

Bunkerhill AVC

Bunkerhill AVC demonstrates superior enterprise readiness with explicit statements of HIPAA compliance and the availability of a Business Associate Agreement (BAA). Its deep integration with EHRs and clinical archives, customizable AI agents, and proactive engagement in establishing CMS reimbursement pathways highlight its robust design for large-scale healthcare system adoption.

Innovation

Bunkerhill AVC

Bunkerhill AVC showcases greater innovation through its use of generative AI for comprehensive clinical reasoning, opportunistic detection of multiple conditions from existing imaging data, and natural language processing for interactive patient record analysis (Carebricks Chat). This advanced AI-driven approach aims to automate workflows and enhance decision-making across diverse data sources.

Support & Docs

AT-Patch (ATP-C130/ATP-C70)

AT-Patch provides readily available user manuals and quick manuals for its device and app, and explicitly offers contact with product specialists for support. While Bunkerhill Health details its internal security and business continuity, it lacks explicit mentions of user-facing support documentation for its platform in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AT-Patch (ATP-C130/ATP-C70) Bunkerhill AVC
Name AT-Patch (ATP-C130/ATP-C70) Bunkerhill AVC
Company ATsens Co. BunkerHill Health
Primary Function/Category Ambulatory ECG Monitor for Continuous Cardiac Monitoring; Cardiology AI, Wearables & Remote Monitoring (RPM) Generative AI platform for clinical reasoning and action; Cardiology AI, Clinical Decision Support & Reference
Key AI Functionality AI/machine learning algorithms for ECG analysis (arrhythmia detection). Generative AI for clinical reasoning and action; automated detection and quantification of aortic valve calcification, coronary artery calcification, mitral annular calcification; opportunistic bone density assessment.
Monitoring/Detection Scope Up to 14 days of continuous ECG monitoring for arrhythmia detection. Early detection and quantification of aortic valve calcification, coronary artery calcification, mitral annular calcification from chest CTs; opportunistic bone density assessment.
Patient Interaction / Data Access AT-Note smartphone app for live ECG viewing and symptom recording. Natural language processing for patient record interaction (Carebricks Chat); integration with EHRs.

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Bunkerhill AVC.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AT-Patch is an FDA-cleared wearable ECG monitor designed for up to 14 days of continuous cardiac monitoring, utilizing AI-powered analysis for enhanced arrhythmia detection. Bunkerhill AVC is a generative AI platform with an FDA-cleared algorithm specifically for the early detection and quantification of aortic valve calcification from chest CTs, along with other cardiac calcifications and opportunistic bone density assessments.
The AT-Patch functions as a wearable device for patients, with its analysis software deployed on-premise at medical institutions. In contrast, Bunkerhill AVC integrates directly with full Electronic Health Records (EHRs) and clinical archives within health systems.
AT-Patch acquires and analyzes continuous electrocardiogram (ECG) signals directly from a patient via its wearable device. Bunkerhill AVC analyzes existing chest CT scans to detect and quantify various cardiac calcifications and opportunistically assess bone density.
AT-Patch is intended for use across Cardiology, Family Medicine, and Internal Medicine. Bunkerhill AVC primarily targets Cardiology and Radiology specialties.
AT-Patch is likely HIPAA compliant given its FDA clearance and operation within the US healthcare system for patient data, but a Business Associate Agreement (BAA) is not explicitly mentioned. Bunkerhill AVC is explicitly HIPAA compliant and confirms it has a Business Associate Agreement (BAA).
AI Tool Finder
AI-powered search. Results may not be comprehensive.